ABSTRACT
INTRODUCTION
Regular physical activity lowers blood pressure (BP) and is an effective strategy for the prevention and treatment of hypertension (HTN). [1, 2] However, there are reports of a substantial proportion of athletes fulfilling diagnostic criteria for HTN. [3] Importantly, as increased BP in youth is prognostic of the development of cardiovascular disease, [4, 5] screening for HTN in young athletes may have implications for primary prevention. U.S. guidelines have recently revised the thresholds for diagnosing HTN from ≥140/90 mmHg to ≥130/80 mmHg in adults [6] and adolescents. [7] In contrast, European guidelines currently recommend ≥140/90 mmHg as the thresholds defining HTN in adults, [8] as do current guidelines for diagnosing HTN in athletes. [9] The Stanford Sports Cardiology program has facilitated pre-participation evaluation (PPE) for pre-college, college and professional athletes for the last decade. The lowering of thresholds for HTN at PPE may identify athletes with higher cardiovascular risk, providing an opportunity for primary prevention. This needs to be balanced by the fact that these thresholds used in the new U.S. guidelines may result in higher number of athletes being referred for unnecessary HTN monitoring. [10] Furthermore, methodology in the assessment of BP at PPE may play a role in the interpretation of these data.
One consequence of chronically elevated BP is left ventricular (LV) remodeling, with increased LV mass (LVM) and concentric remodeling, leading to LV dysfunction. [11, 12] There is evidence of an impact of BP and HTN on cardiac remodelling and function already in children. [13, 14] LV remodeling is also an established feature of the athlete's heart, [15, 16] however the physiological remodeling is proportional and the LV mass/volume ratio (MVR) and LV function are maintained. [17, 18] Thus, considering the LV remodeling pattern in addition to LVM could provide insight as to the clinical significance of BP assessed during PPE.
The objectives of our study were (i) to evaluate BP measured during PPE in a large heterogeneous cohort of young athletes in the context of recently updated HTN guidelines, (ii) to explore the demographic and anthropomorphic determinants of BP in this population and (iii) to evaluate the impact of BP on LV remodeling and function in a group of college athletes.
METHODS

Study design
This retrospective study was composed of two cohorts (Supplementary Figure 1 image quality allowing for calculation of LVM and volume; (ii) records of (a) resting BP the same day as echocardiography and (b) demographic and anthropomorphic measures. Exclusion criteria were (i) known HTN and/or current BP medication or (ii) pathological findings on echocardiogram. For the purpose of this study, the term 'football' describes American-style gridiron football, and 'soccer' describes the sport in Europe termed football. All participants signed a consent form approved by the institutional review board at Stanford University.
Pre-participation clinical evaluation (PPE)
PPE was performed by experienced medical personnel (a sports cardiologist with support by nurses) either at Stanford University (collegiate athletes), at the athlete's sport club (professional athletes) or in a community setting (pre-college athletes), adopting the AHA 14-Element model [19] (personal/family history and physical examination) with the addition of a 12-lead ECG. Height and weight were measured, and ethnicity was self-reported. The final determination and follow up of PPE results, including ECGs, were made by an experienced sports cardiologist.
Measurement and classification of blood pressure
Resting BP was obtained at the time of PPE (cohort 1) or at the echocardiographic examination (cohort 2) using standard protocols. [9, 20] Briefly, BP was measured in both arms using an automated oscillometric cuff positioned at the level of the heart (in a majority of observations with Spot Vital Signs, Welch Allyn Inc., NY, USA), assuring proper cuff-size. Subjects were positioned seated with the forearm rested flat on a supportive surface after at least 5 minutes of rest. The higher value in either arm was reported, and in cases of which the initial reading was ≥140/90 mmHg, BP was remeasured in both arms. If still exceeding 140/90 mmHg after remeasurement, follow-up was recommended with the primary care or sports physician.
Blood pressure was categorized per the 2017 U.S. (American Heart Association/American College of Cardiology) and 2018 European (European Society of Cardiology) guidelines for HTN ( Figure 1A ). [6, 8] 
Athletic Echocardiography Screening Protocol
Echocardiography was performed using a commercially available system (iE33; Philips Medical Imaging, Andover, MA, USA). The echocardiographic protocol included 2-D and color Doppler, parasternal and apical views. Images were analysed on Xcelera workstations. Standard measures of LV size, LV ejection fraction (LVEF) and diastolic parameters were performed. LVM and volume (LVEDV) were calculated using the area-length method in end-diastole from short-axis and apical 4-chamber images and indexed to body surface area (BSA). MVR was derived by dividing LVM and LVEDV. [21] In diastole, the relative wall thickness (RWT) was calculated from short-axis images as [(2 × average wall thickness)/LV diameter] and LV sphericity index was determined as (LV length in the apical 4-chamber view/LV diameter in short-axis view). Mid-wall LV Langrangian longitudinal strain (LS, %) was calculated from apical 4-chamber images by manual tracings of ventricular length ([L1-L0]/L0×100), where L1 represents end-systolic and L0 enddiastolic wall length. [22] 
Statistical analysis
Continuous data were expressed as mean ± SD, categorical data as number of observations and frequency.
For BP, upper 95th percentiles were calculated. Differences between groups were evaluated using oneway ANOVA or Student's t-test for continuous variables and Chi² test for categorical variables. P-values rowing (8.8%), basketball (7.9%) or baseball (7.0%). Professional athletes differed demographically from others in that 89.0% were football players, 97.2% were male and 58.7% were of African-American decent.
Average SBP was higher in males than in females at all seniority levels, while DBP only differed between sexes in college athletes ( Figure 2 ). In unadjusted analysis, average SBP varied from 117±11 mmHg and 117±12 in soccer players and cross-country runners, respectively, to 125±14 mmHg in football players, which was associated with a corresponding difference in age between sports ( Figure 3 ). There was no difference in BP between male football players at a college vs. professional level; overall or in subgroups of athletes of either Caucasian or Afro-American ethnicity (Supplementary table 2). Of all athletes, 34.3% (n=938) and 8.8% (n=241) had a SBP and/or DBP exceeding the HTN thresholds in the U.S. and European guidelines, respectively ( Figure 1B) . With the U.S. guidelines, 6.6 times as many females (22.0 vs. 3.3%) and 3.4 times as many males (42.5 vs. 12.5%) exceeded the threshold for HTN compared to using European guidelines. Out of the athletes with a BP exceeding any threshold for HTN by the U.S. guidelines, 38.9% fulfilled only SBP criteria (i.e. DBP <80 mmHg), 34.6% only DBP criteria (i.e. SBP <130 mmHg) and 26.5% fulfilled both criteria ( Figure 1C) . Details on the number of athletes by seniority level and sex exceeding respective threshold is presented in Supplementary figure 3.
Male sex, age, height, weight, BMI and Afro-American decent were all weak to moderate, unadjusted correlates of BP, with stronger correlations to SBP than DBP (Supplementary table 3) . When adjusting for sex, age, Afro-American ethnicity, height and BMI, age had no independent association with SBP and BMI was the only factor associated with SBP in all seniority levels( Table 2) 
Stanford Pre-participation Echocardiographic Screening Cohort
In the 304 college athletes (age 17-26 years) in cohort 2 (Table 3) , there were 219 football players (all male), 43 basketball players (20 male) and 42 volleyball players (25 male). Overall, 139 (45.7%) of athletes had a BP ≥130 and/or ≥80 mmHg and 43 (14.1%, all male) had a BP ≥140 and/or ≥90 mmHg. Athletes in higher BP categories had higher BMI, were more likely football players and male, and they had larger absolute and indexed LVM. RWT and MVR were greater in higher BP categories (both p<0.001), while LV sphericity index was similar across groups (p=0.391). The difference in MVR between groups is visualized in Figure 3 . There was no difference in LV function as measured by LVEF and LV LS between groups, while diastolic E/A-ratio was lower with increasing BP (p<0.001) and there were trends towards lower e' and Ewave velocity in higher BP groups (p=0.105 and 0.102, respectively). 0.563 *, ≥130 and/or ≥90 mmHg corresponds to the threshold defining hypertension in the current U.S. guidelines, while ≥140 and/or ≥90 mmHg correspond to current European guidelines; **. Data on ethnicity was missing for one of the athletes in the <120/<80 mmHg group; ***, Sphericity index was determined as (left-ventricular (LV) length in the apical 4-chamber view/LV diameter in short-axis view). BMI, body mass index; BSA, body surface area; LVM, LVMI and LVEDV, LVEDVI, left-ventricular mass and end-diastolic volume with and without indexing for BSA, respectively; MVR, LV mass/volume ratio; RWT, relative wall thickness; LVEF, left-ventricular ejection fraction; LS4Ch, longitudinal strain (4 chamber view); E and A, early and late diastolic mitral inflow velocities; e'lateral, early diastolic velocity of the basal lateral leftventricular wall. 
DISCUSSION
The main finding of our study is that in a large cohort of athletes undergoing PPE, BP exceeded the thresholds recommended in the new U.S. guidelines in one third of athletes, four times as many as with the European guidelines. Although mean BP increased with seniority level; height, BMI and sex rather than age appeared to explain the variability in SBP. Furthermore, we observed that athletes in higher BP categories presented with a greater degree of concentric LV remodeling (greater MVR) and with differences in diastolic function as compared to those in lower BP categories.
BP in relation to recent HTN guidelines
There was a large discrepancy in the number of athletes exceeding the thresholds defining HTN using the current U.S. versus European guidelines (34.3 vs 8.8%), especially in females (22.0 vs 3.3%). This reflects the fact that many of the athletes in our cohort had a SBP/DBP between 130-140/80-90 mmHg ( Figure   1C ). Current recommendations for BP measurement and HTN management in athletes (published in 2015), [9] based on the now former U.S. guidelines, [20] recommend that an initial reading of ≥140/≥90 mmHg (8.8% in our cohort) should be followed-up for HTN. Thus, adopting the thresholds in the new U.S. guidelines for BP screening could have a large impact on the number of athletes recommended for followup for HTN.
A clinical diagnosis of HTN is based on BP measurements on at least two separate occasions, [6] [7] [8] which precludes a HTN diagnosis for the athletes in our study. The comprehensive recommendations for BP measurement standardisation within the guidelines [6, 8] can be challenging to adopt, or fully adhere to in the PPE setting, which may be reflected in the large variability in the protocols used for BP measurement across previous studies reporting BP in athletes. [3] Although the PPE situation may vary considerably between institutions and countries, common difficulties in acquiring optimal BP measurements include logistic issues (time constraints, many athletes or a team screened at a single occasion) as well as the sometimes stressful, unfamiliar environment for the athlete. By adding ambulatory BP measurements to screening BP in athletes, studies have reported a high prevalence of both white coat HTN [23] as well as masked HTN. [23, 24] Thus, a second BP measurement on a separate day (when feasible) or remeasuring BP in all athletes with an initial reading of ≥130/≥80 mmHg would probably result in lower reported BP values. If lower BP thresholds are to be introduced at PPE, this should come with a high level of adherence to the strict standardisation of BP measurements advocated by the guidelines. [6, 8, 9] While the findings of the current study need to be interpreted in the context of the ongoing challenges in standardisation, our results clearly demonstrate the impact of adapting different thresholds for defining elevated BP or HTN during PPE. While this screening has continuously evolved to more reliably detect underlying cardiac diseases predisposing athletes to sudden cardiac death, [19] we would like to offer a note of caution before implementing thresholds derived from and evaluated in other settings, without also adopting stricter protocols for measurement. [4, 6, 7] 
Factors associated with BP in youth and in young athletes
Systolic BP increased from pre-college to professional athletes, paralleled by an increase in age, height, weight and BMI. Male sex was associated with higher SBP at all seniority levels. While height and BMI were the strongest independent predictors of SBP in our cohort, age was not associated with SBP in adjusted analysis. Our cohort appears representative of contemporary athletes with mean SBP consistent with the averages from 51 original articles on BP in athletes summarized in a meta-analysis by Berge et al. (2015) : 114/72 (females) and 121/75 mmHg (males), with only marginally higher values in the current study. [3] The association between height and BP in children in and adolescents is established, [7] as is the higher prevalence of HTN in young subjects with high BMI. [14, 25, 26] Direct comparison between the prevalence of HTN in our athletes to a general young adult or adolescent U.S. population is difficult, considering the use of different definitions of HTN over time and between studies. [7, 25] In 761 subjects aged 12-17 years from the National Health and Nutrition Examination Survey, [25] the prevalence of either high or borderline high BP was 15%, similar to what has been reported in urban student athletes. [26] The proportion of athletes exceeding the updated, lower thresholds for HTN in our group of pre-college athletes was 36.5% in males and 25.5% in females, respectively. These data reinforce a concerning prevalence for elevated BP in the adolescent population and highlights that athletic populations are not immune to cardiovascular risk factors. As both BMI and BP in adolescence and young adulthood have been coupled to adult cardiovascular disease and mortality, [4] PPE in this population may represent an opportunity for early intervention.
Cardiac remodeling in athletes in relation to BP
Greater LVM and LVEDV is a common finding in competitive athletes when compared to untrained subjects, [15] and is considered to represent a physiological remodeling in response to repeated volume load during endurance exercise training. [16] This remodeling is generally reported as proportional, represented by similar wall/cavity ratio (RWT) [15, 27] and mass/volume ratio (MVR) [17, 28] as in untrained subjects. While MVR and RWT in the athletes of the current study were within normal limits compared to previous observations, [21] athletes with higher BP had higher MVR and RWT than those with lower BP. In addition, SBP assessed during PPE was linearly associated with MVR independently of ethnicity and BMI.
BP level measured in healthy non-athletic children and adolescents has previously been shown to correlate with LV mass [13, 14] as well as to LV concentric remodeling, [14] and recently to predict adult LV concentric hypertrophy. [29] In addition, Trachsel et al. (2015) reported higher MVR in middle aged marathon runners with masked HTN than in normotensive runners. [24] Our results extend these previous findings to a group of young, presumptuously healthy athletes, suggesting that the process of adverse cardiac remodeling from chronically elevated BP may begin as early as college level. In addition, although LV systolic function at rest was similar across BP categories, those with higher BP presented with lower E/A-ratio and trends towards lower E-wave and e' velocities, all markers of diastolic function. Diastolic dysfunction is prevalent in hypertensive heart disease, already at a young age, [30] and is thought to precede more severe LV dysfunction. [11] Whether our findings reflect subclinical diastolic dysfunction or if they simply are a physiological marker of increased BP remains to be elucidated.
Limitations
First, the retrospective design holds several limitations. As follow up was completed by the athlete's primary health care team we were unable to obtain serial BP measurements and review outcomes in this cohort. Optimally, BP should have been remeasured at the level of 130/80 mmHg in concordance with the current guidelines. Future study designs should endeavor to include ambulatory or in office measurement to validate our findings. Second, echocardiography findings presented from cohort 2 were from a relatively small cohort (n=304), of which a large proportion were male football players, and will require further validation. Third, ethnicity was self-reported with minimal or no guidance, which is inferior to using guided interviewing or, optimally, genetically determined ancestry. Finally, the use of cardiac magnetic resonance imaging would provide a more precise measure of LV remodelling; however, this modality is impractical in PPE and echocardiographic determined measures can be more readily utilized in the clinical sports cardiological setting.
Conclusions
Height, BMI and sex (and not age) explained most of the variability in SBP in our large, heterogenous cohort of athletes, in which a substantial proportion of athletes presented with a BP above the threshold for HTN per current U.S guidelines. The independent associations between BP and cardiac remodelling suggest that elevated BP in athletes during PPE may signify a clinically relevant condition. However, before considering the lower BP thresholds, efforts for standardizing BP measurements at PPE need to be undertaken. 
